 A subset of lung adenocarcinomas harboring an EML4-ALK fusion gene resulting in dominant oncogenic activity has emerged as a target for specific therapy.     ///    EML4-ALK fusion confers a characteristic histology and is detected more frequently in never or light smokers and younger patients. 